@Article{Stachowiak2010,
journal="Menopause Review/Przegląd Menopauzalny",
issn="1643-8876",
volume="9",
number="3",
year="2010",
title="What\’s new in the treatment of female pelvic inflammatory disease?",
abstract="Pelvic inflammatory disease (PID) is a large group of inflammatory polymicrobial illnesses of female genital organs, mostly caused by Chlamydia trachomatis and Neisseria gonorrhoeae. When poorly treated it leads to  some serious distant side effects e.g. impaired fertility. Quinolones play an important role in the treatment of PID, whereas newly introduced moxifloxacin is characterized by high therapeutic efficacy and safety.",
author="Stachowiak, Grzegorz
and Pertyński, Tomasz",
pages="140--144",
url="https://www.termedia.pl/What-8217-s-new-in-the-treatment-of-female-pelvic-inflammatory-disease-,4,14873,1,1.html"
}